Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mepolizumab Pharmacokinetics Among Patients With Severe Asthma: Protocol for a Case Control Study Comparing Clinical Responders Versus Non Responders

NCT05495932 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05495932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mepolizumab Pharmacokinetics Among Patients With Severe Asthma: Protocol for a Case Control Study Comparing Clinical Responders Versus Non Responders
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
November 15, 2022
Completion date
December 20, 2024
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma